Ortho Clinical Diagnostics today announced it will present seven scientific posters on its assays and display six products at its booth at the 2016 American Association for Clinical Chemistry (AACC) ...

• Fourth quarter Core revenue grew 3.5% to $518.9 million, or 4.3% in constant currency and 8.0% excluding CoV-2 assay sales • Fiscal year Core revenue grew 16.1% to $2.01 billion, or 14.6% in ...

Johnson & Johnson announced Thursday that it is selling its Ortho-Clinical Diagnostics business for $4.2 billion to the Carlyle Group. This continues a strategy to focus on growing businesses In a ...

(Reuters) - Private equity firm Carlyle Group LP is exploring a sale or initial public offering of Ortho-Clinical Diagnostics Inc, a U.S. diagnostics company that could be valued at more than $7 ...

Ortho Clinical Diagnostics (OCDX) went public in January 2021, raising approximately $1.3 billion in gross proceeds from an IPO that priced at $17.00 per share.The firm provides diagnostics services ...

Quidel Corp. reported a definitive agreement to acquire Ortho Clinical Diagnostics Holdings plc in a nearly $6 billion deal expected to close in the first half of 2022. The $24.68 per share offered by ...

SAN DIEGO--(BUSINESS WIRE)-- Quidel Corporation (Nasdaq: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced ...

Wall Street's main indexes rose for a third straight session on Thursday after early data suggested that the Omicron variant of the coronavirus was less severe than feared, lifting the mood ahead of ...